<body data-rsssl=1 class=

About admin

This author has not yet filled in any details.
So far admin has created 44 blog entries.

Evacuating to a Public Shelter During COVID-19

A public shelter may be the only safe option for some people who have to evacuate during an emergency or disaster. Whether you are evacuating due to a wildfire, tornado, or hurricane, it is important to be prepared and take steps now to help protect yourself and others from COVID-19. Know a safe place to

By |2020-09-23T13:18:32+00:00July 23rd, 2020|Uncategorized|0 Comments

CMS Directs Additional Resources to Nursing Homes in COVID-19 Hotspot Areas

CMS announced a targeted approach to provide additional resources to nursing homes in Coronavirus Disease 2019 (COVID-19) hotspot areas. Specifically, CMS plans to: Deploy Quality Improvement Organizations (QIOs) across the country to provide immediate assistance to nursing homes in the hotspot areas as identified by the White House Coronavirus Task ForceImplement an enhanced survey process

By |2020-09-23T12:10:30+00:00July 23rd, 2020|Uncategorized|0 Comments

Special COVID-19 Webex Recording Now Available Online

If you missed the recent Special COVID-19 Webex, Dialyzing Patients in Skilled Nursing Homes During COVID-19, the recording is now available online. Speakers included Alice Hellebrand, Chief Nursing Officer of Dialyzer Direct; and LaKeisha Jones, Vice President of Clinical Services of Concerto Renal Services. They discussed the new structure for dialysis patients in nursing homes

By |2020-09-23T12:10:21+00:00July 23rd, 2020|Uncategorized|0 Comments

4e Brands North America Issues Nationwide Voluntary Recall of Hand Sanitizer

San Antonio, Texas, 4e Brands North America is voluntarily recalling ten (10) bottle sizes of Hand Sanitizers to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol). Risk Statement: Substantial methanol exposure could result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the

By |2020-09-23T12:09:46+00:00July 15th, 2020|alerts|0 Comments

Letter to Health Care Providers- Important Information on the Use of Serological (Antibody) Tests for COVID-19

The U.S. Food and Drug Administration (FDA) recommends that health care providers continue to use serological tests intended to detect antibodies to SARS-CoV-2 to help identify people who may have been exposed to the SARS-CoV-2 virus or have recovered from the COVID-19 infection. Health care providers should also be aware of the limitations of these

By |2020-09-23T12:08:46+00:00June 29th, 2020|alerts|0 Comments

Education Corner: The Opiod Crisis

CMS, State, and local communities, continue to promote safe and responsible pain management; however, Opioid Use Disorder (OUD), overdoses, and deaths continue to be a growing concern. The following links and tools can help you better understand the current crisis and assist your patients with effective pain management if needed. Pain Management Zone ToolCMS Roadmap:

By |2020-09-23T12:09:03+00:00June 17th, 2020|Uncategorized|0 Comments

5-Diamond Patient Safety COVID-19 Module

A COVID-19 module has been added to the 5 Diamond Patient Safety Program website and is available for any dialysis provider to access. The module was developed in partnership with the American Society of Nephrology (ASN). Objectives for the module include: Discuss COVID-19, including what it is and how it spreads. Identify symptoms of COVID-19. Describe

By |2020-10-14T19:35:17+00:00June 17th, 2020|Uncategorized|0 Comments

Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment

AUDIENCE: Health Professional, Pharmacy, Patient ISSUE: FDA is warning health care providers that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir. The agency is not aware of instances of this reduced activity occurring in the clinical setting but, is continuing to evaluate all

By |2020-09-23T12:09:36+00:00June 17th, 2020|alerts|0 Comments

Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, Due to Detection of N-Nitrosodimethylamine (NDMA) Impurity

Amneal Pharmaceuticals LLC Bridgewater, New Jersey (Amneal), is voluntarily recalling all lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, within expiry to the Retail Level. Amneal was notified by the U.S. FDA that the Agency’s testing of seven lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750

By |2020-09-23T12:09:27+00:00June 4th, 2020|alerts|0 Comments

Use the Correct Cycle and Compatible N95 Respirators When Decontaminating Respirators with STERRAD Sterilization Systems – Letter to Health Care Providers

The U.S. Food and Drug Administration (FDA) reminds reprocessing staff in health care facilities to use the correct decontamination cycle associated with certain models of the Advanced Sterilization Products (ASP) STERRAD Sterilization Systems and to only decontaminate compatible N95 or N95-equivalent respirators for reuse during the COVID-19 pandemic. ASP STERRAD Sterilization Systems use vaporized hydrogen

By |2020-09-23T12:09:18+00:00May 30th, 2020|alerts|0 Comments